DoD Peer Reviewed Cancer Research, Career Development Award

Description

The PRCRP is seeking to advance cancer research through development of early career investigators. Dependent on the accomplishments of candidates, the PRCRP will offer two distinct early career development options: the Fellow Option (CDA-FO) and the Virtual Cancer Center Scholar Option (CDA-SO). Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development. Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated. This award supports impactful research projects with an emphasis on discovery. · Fellow Option: Supports independent, early-career investigators (referred to as Fellows) to conduct impactful research with the guidance of an experienced cancer researcher (i.e., Career Guide). Presents an opportunity for Fellows to obtain the funding, guidance, and experience necessary for productive, independent careers at the forefront of cancer research. Fellows will not be formally part of the Virtual Cancer Center. For more information, refer to the FY20 Virtual Cancer Center Director Funding Opportunity (W81XWH-20- PRCRP-VCCDA). · Virtual Cancer Center Scholar Option: Supports independent, highly accomplished early career investigators (referred to as Scholars) to conduct impactful research under the guidance of an experienced cancer researcher (i.e. Career Guide). Presents an opportunity for Scholars to participate in the unique, interactive Virtual Cancer Center (VCC) focused on fostering the next generation of cancer researchers. This award provides intensive mentoring, national networking, and a peer group for junior faculty. Scholars are required to interact with the VCC Director, Deputy Director, and fellow Scholars in addition to their Career Guide. For more information on the Virtual Cancer Center refer to the FY20 Virtual Cancer Center Funding Opportunity. It is the responsibility of the PI to select the option that best aligns with their current career stage. The option should be selected based on the eligibility defined in the Program Announcement, and not on the amount of the budget. It is incumbent upon the early career investigator to select the suitable option. A Congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer- Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY20 PRCRP priorities.

Agency Contact

More from Defense Health Agency Contracting Activity - DHACA